APA (7th ed.) Citation

D, N., L, Z., HJ, M., T, J., P, D., B, S., . . . VS, K. (2022). APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer. Frontiers in oncology, 12, 816706. https://doi.org/10.3389/fonc.2022.816706

Chicago Style (17th ed.) Citation

D, Natesan, et al. "APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer." Frontiers in Oncology 12 (2022): 816706. https://doi.org/10.3389/fonc.2022.816706.

MLA (9th ed.) Citation

D, Natesan, et al. "APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer." Frontiers in Oncology, vol. 12, 2022, p. 816706, https://doi.org/10.3389/fonc.2022.816706.